Risks and benefits in numbers

In short

Coloscopy is a low-risk procedure with meaningful benefits, but it is not without risk. Serious complications — perforation of the bowel, significant bleeding, sedation-related events — are uncommon, with rates reported well below one percent in published series of routine procedures. The benefits are larger when polyps are found and removed, and smaller when nothing is found, but the test still rules things out, which has its own value. Honest comparison requires looking at both sides.

What this page covers

The recognised risks of coloscopy and what each one really means; the benefits — preventive, diagnostic, and reassurance; how risks change with age, comorbidity, and whether the test is therapeutic; and how to weigh the trade-off if you are deciding whether to go ahead.

Bowel perforation
Bleeding
Sedation-related events
Infection
Post-procedure pain and discomfort
The benefits — what coloscopy actually achieves
How risk changes with age and other factors

Bowel perforation

Perforation means a small tear in the wall of the colon. It is the most-discussed serious complication because, when it occurs, it can require admission to hospital and sometimes surgery, with several days of recovery. In large modern series of diagnostic coloscopies, the reported risk is consistently below one in a thousand. The risk rises somewhat when polyps are removed, particularly when they are large, located in the right side of the colon, or technically demanding to take off, but even with polypectomy the risk is reported under one percent in most published series.

Most perforations are recognised either during the procedure or in the hours after it. Symptoms include severe abdominal pain that worsens rather than settling, a swollen, tense abdomen, fever, and sometimes shoulder-tip pain (which reflects gas under the diaphragm). Many small perforations can now be repaired endoscopically with clips at the time of recognition, avoiding open surgery. The page on when to call your doctor after covers the warning signs that should prompt an urgent call.

Bleeding

Bleeding after coloscopy is most commonly associated with polyp removal rather than diagnostic-only inspection. After a polypectomy, the small wound on the bowel wall may bleed at the time, in which case the endoscopist treats it during the same procedure, or some hours to days later — so-called delayed post-polypectomy bleeding. The reported risk varies with polyp size, location, technique, and whether you are taking blood thinners, but is generally well under one in a hundred for diagnostic coloscopies with small polyps and somewhat higher for more complex resections.

Most post-polypectomy bleeding stops without intervention; some requires a repeat coloscopy to apply clips or to coagulate a vessel; a small minority require admission for transfusion. The page on blood thinners and antiplatelets covers how medication management before the test affects this risk.

Sedation-related events

If you receive sedation, the most common adverse effects are temporary low blood pressure, slowed breathing, and oxygen desaturation, all of which the team monitors and treats. Serious sedation-related events — those requiring reversal medication, airway intervention beyond simple manoeuvres, or transfer to a higher level of care — are reported at rates well under one percent in published series across both midazolam-and-fentanyl regimens and propofol-based deep sedation.

People with significant cardiac or respiratory disease, sleep apnoea, or a history of difficult sedation have these factors discussed in detail before the test, and may be offered propofol with anaesthesia involvement as a precaution. The sedation options page covers this in more depth.

Infection

The risk of infection after coloscopy is small. Coloscopes are reprocessed between patients to standards set by national regulators, and although outbreaks have been reported with other types of endoscope used in the upper gastrointestinal tract, transmission via coloscopy is rare. Antibiotics are not routinely given before the test for most adults; specific high-risk situations are discussed individually.

Some people develop a urinary tract infection in the days after — possibly from the prep or from being away from usual fluid intake — rather than from the procedure itself.

Pain, bloating, and other minor effects

It is common, not abnormal, to feel bloated and crampy in the hours after a coloscopy. The bowel was inflated for the inspection, and although modern units use carbon dioxide that the body absorbs quickly, some residual gas takes a little while to clear. Walking helps, and so does the trip to the toilet. Persistent or worsening pain, particularly with fever, abdominal swelling, or rectal bleeding more than spotting, is not a normal recovery and should be reported. See the first twenty-four hours.

Other rare events

Coloscopy is also reported to cause, very rarely, splenic injury (from the splenic flexure being stressed), short-lived bacterial seeding into the bloodstream of no clinical consequence, and post-polypectomy electrocoagulation syndrome (delayed pain and inflammation at a polypectomy site that resembles a perforation but does not always involve a hole). These are uncommon enough that a patient is unlikely to encounter them, but a thorough consent conversation will mention them.

Benefits — what the test actually achieves

The benefits depend on why you are having the test.

Detection and removal of precancerous polyps. Most colorectal cancers begin as polyps that grow slowly over years before becoming cancer. Removing these polyps interrupts the sequence. Population studies of screening coloscopy and post-polypectomy surveillance have demonstrated reductions in colorectal cancer incidence and mortality, and this benefit is the central rationale for the test as a screening modality.

Detection of cancer at an early stage. A small minority of coloscopies find an existing cancer. When found early, before symptoms have appeared, treatment is generally less extensive and outcomes better than when found late. This is true whether the cancer was found through screening, on workup of a positive stool test, or in investigation of a symptom.

Diagnosis of non-cancer conditions. Coloscopy can identify inflammatory bowel disease, microscopic colitis (when paired with biopsies in someone with persistent diarrhoea), severe diverticular disease, and bleeding from haemorrhoids or other localised lesions. Reaching the right diagnosis directs treatment and stops further unnecessary investigation.

Reassurance. A clean coloscopy in someone with anxiety-provoking symptoms — visible blood from haemorrhoids, for example — provides genuine, durable reassurance that the major worry has been excluded. This is not a small benefit even though it does not always feel like a "result".

Putting risk and benefit together

The honest framing is this. For most adults at average risk being screened, the absolute benefit of any one coloscopy is modest — most tests find nothing and most lives saved are saved by the small minority of tests that find an early cancer or a high-risk polyp. The absolute risk of serious harm from any one test is small. Across a population, the benefit clearly exceeds the risk; for any individual person, both numbers are small.

For people at higher risk — strong family history, prior polyps, inflammatory bowel disease, inherited syndromes — the benefit is concentrated. The test is more likely to find something and more likely to change what happens next.

For people undergoing therapeutic procedures — large polyp removals, treatment of bleeding — both risk and benefit are higher than for diagnostic-only tests. The conversation with the endoscopist about expected difficulty and expected gain matters more.

For older adults and those with significant illness, age and frailty change the calculus. The page on older adults and when to stop screening walks through how this is usually weighed.

How risks change with circumstances

Several factors push procedural risk slightly up or down:

Age. Risks of perforation, bleeding, and sedation events all rise modestly with age. None becomes large in absolute terms; the increase is real and worth knowing.
Comorbidity. Heart, lung, and kidney disease change sedation risk. Cirrhosis and bleeding disorders change bleeding risk.
Medications. Anticoagulants and antiplatelets raise bleeding risk in the days after polypectomy. The endoscopist may advise a temporary pause or switch — never on your own initiative — see blood thinners and antiplatelets.
Anatomy and prior surgery. Adhesions, prior pelvic surgery, severe diverticulosis, and certain congenital variations make the test technically more demanding and slightly raise the risk of perforation.
The polyp itself. Larger polyps, polyps in the right side of the colon, and flat polyps that need advanced techniques (endoscopic mucosal or submucosal resection) carry meaningfully higher risk than the snaring of small polyps. These risks are usually discussed in a separate consent conversation when the test is planned for therapy rather than discovered during it.

Risk of not having a recommended coloscopy

If a coloscopy is recommended for screening, declining it does not put you in a "no risk" baseline — it puts you in the baseline risk of colorectal disease for someone of your age. If it is recommended for surveillance after polyps, declining it leaves the surveillance question unanswered. If it is recommended for investigation of a symptom or a positive stool test, declining it means the question that prompted the test stays unanswered, and a different test, if one exists, may not give as definitive an answer.

Risks of inaction are usually larger than risks of the procedure for the indications under which coloscopy is recommended in current guidelines. That does not make the procedural risk vanish — both can be real at the same time.

What to ask your clinician

What are the specific risks for me, given my age, medications, and history?
What is this unit's quality data — how often does perforation or significant bleeding occur here?
If I am taking a blood thinner or antiplatelet, how should it be managed around the test?
What are the warning signs in the days after the test that should prompt me to call?
If a complex polypectomy is planned, what additional risks should I understand?
How does the risk for me compare with the risk of not having the test, given my indication?
What is the practical benefit if my test is normal — what does it close off, and for how long?

Common worries, briefly addressed

People die from coloscopies. Is that true?

Mortality from coloscopy is reported, but at very low rates — well below one in ten thousand procedures in most published series, often considerably lower. Most deaths are related to severe procedural complications occurring in already very unwell patients. The risk is not zero, and pretending otherwise would be dishonest, but it is among the lowest for procedures of this kind.

I have a friend who had a complication. Should I be more worried?

Anecdotes are vivid and population statistics are dry, and both are true. Knowing someone who had a complication does not change your own risk, but it can make the abstract numbers feel more concrete than they are. Your individual risk is shaped by the factors above, not by your social network's experience.

Why does the consent form list so many things?

Consent forms list known complications including very rare ones, because people have a right to be told what is possible. The presence of an item on the form does not make it likely.

Are the benefits exaggerated by the people offering the test?

This is a fair question. Independent bodies — the U.S. Preventive Services Task Force, the European Society of Gastrointestinal Endoscopy, the National Institute for Health and Care Excellence — have looked at the evidence and made recommendations that you can read in their own words. Their reasoning is more measured than typical clinic-room conversation, in either direction.

If I am healthy, can I just skip it?

You can decline any test. The relevant question is what you would do instead. A non-coloscopy screening modality, repeated reliably over time, is a real option for many people at average risk. Doing nothing is a different choice and worth being honest with yourself about.

Sources

U.S. Preventive Services Task Force — recommendation statement on colorectal cancer screening, including evidence on harms
American Society for Gastrointestinal Endoscopy — adverse events of lower gastrointestinal endoscopy
American College of Gastroenterology — quality indicators and complication rates in coloscopy
European Society of Gastrointestinal Endoscopy — performance measures and complications
British Society of Gastroenterology — coloscopy quality and safety standards
Canadian Association of Gastroenterology — position statements on procedure-related risk
National Institute for Health and Care Excellence — coloscopy and bowel-cancer screening guidance